Skip to main content

Metabolische Osteopathien

  • Chapter
Medizinische Therapie 2005|2006
  • 34 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bilezikian JP, Raisz LG, Rhodan GA (2000) Principles of bone biology, 2nd Edition. Academic Press, San Diego London Boston New York Sydney Tokyo Toronto

    Google Scholar 

  • Black DM, Greenspan SL, Ensrud KE et al. (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349: 1207–1215

    Article  CAS  PubMed  Google Scholar 

  • Boluki D, Grifka J (2002) Orthesenversorgung bei Osteoporose. In: Praktische Orthopädie, Osteoporose. Steinkopff, Darmstadt

    Google Scholar 

  • Consensus Development Statement (1997) Who are candidates for prevention and treatment for osteoporosis? Osteoporosis Int 7: 1–6

    Google Scholar 

  • Dambacher MA, Neff M (2001) Erworbene Skelettsystemerkrankungen. In: Wirth CJ (Hrsg) Praxis der Orthopädie. Thieme, Stuttgart New York, S 371–414

    Google Scholar 

  • Ettinger B, Black DM, Mitlak BH et al. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA 282: 637–645

    Article  CAS  PubMed  Google Scholar 

  • Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurence of osteoporotic fractures. BMJ 12: 1254–1259

    Google Scholar 

  • McClung MR, Geusens P, Miller PD et al. (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344: 333–340

    Article  CAS  PubMed  Google Scholar 

  • Meunier PJ, Roux C, Seeman E et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in woman with postmenopausal osteoporosis. N Engl J Med 350: 459–468

    Article  CAS  PubMed  Google Scholar 

  • Neer RM, Arnaud CD, Zanchetta JR et al. (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 1434–1441

    Article  CAS  PubMed  Google Scholar 

  • NIH Consensus Development Panel (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285: 785–795

    Google Scholar 

  • Seibel MJ, Stracke H (1997) Metabolische Osteopathien. Schattauer, Stuttgart

    Google Scholar 

  • Uebelhart D, Frey D, Frey-Rindova P, Goerres G, Michel BA (2003) Osteoporosebehandlung: Bisphosphonate, SERM’s, Teriparatide und Strontium. Z Rheumatol 62: 512–517

    CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Schaumburger, J., Grifka, J. (2005). Metabolische Osteopathien. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_46

Download citation

  • DOI: https://doi.org/10.1007/3-540-27385-9_46

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21226-3

  • Online ISBN: 978-3-540-27385-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics